NovImmune SA Initiates Phase I Clinical Study With First-in-Class Anti-TLR4 Monoclonal Antibody
11/28/2012 9:32:14 AM
More...
|
NovImmune SA Release: European Commission Awards a EUR 6 Million FP7 Grant to Support Clinical Development of NI-0501 to FIGHT HLH
10/15/2012 10:12:51 AM
More...
|
NovImmune SA Strengthens Board and Management Team
7/10/2012 10:17:31 AM
More...
|
Genentech (RHHBY) Initiates First-in-Human Study with NovImmune SA's Anti-IL17 Antibody
12/13/2011 9:14:16 AM
More...
|
NovImmune SA Initiates a Proof-of-Concept Study in Primary Biliary Cirrhosis (PBC)
9/22/2011 10:00:34 AM
More...
|
ALGENICS and NovImmune SA Announce a Research Collaboration to Express Fully Human Antibodies Using the Microalgal PTA Cell Line
6/22/2011 10:40:13 AM
More...
|
NovImmune SA Nominates Klaus Strein as New Member of the Board of Directors
5/25/2011 11:24:01 AM
More...
|
NovImmune SA Raises Additional CHF 20 Million ($19 Million)
12/17/2010 6:14:20 AM
More...
|
NovImmune SA Eyes IPO After Licensing Deal With Roche (RHHBY)'s Genentech (RHHBY)
7/26/2010 7:59:19 AM
More...
|
The EUROPEAN BIOTECHNICA AWARD 2009 Goes to NovImmune SA
10/6/2009 8:22:30 AM
More...
|
|